(Q33724455)

28 July 2017

1 reference

title

The potential role of therapeutic cytokine manipulation in acute pancreatitis (English)

1 reference

28 July 2017

Denham W

1

1 reference

28 July 2017

Norman J

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Surgical Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

volume

79

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

767-781

1 reference

Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin-8 and the chemokine family.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Acute pancreatitis: a lethal disease of increasing incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

TNF but not IL-1 decreases pancreatic acinar cell survival without affecting exocrine function: a study in the perfused human pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Role of platelet activating factor in acute pancreatitis induced by lipopolysaccharides in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Intrapancreatic interleukin-1beta gene expression by specific leukocyte populations during acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Specific changes in the pancreatic expression of the interleukin 1 family of genes during experimental acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Inflammatory mediators in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin-8 and neutrophil activation in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Mechanisms of cell death after pancreatic duct obstruction in the opossum and the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Platelet-activating factor: a mediator for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Effects of cycloheximide on pancreatic endonuclease activity, apoptosis, and severity of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Release of platelet-activating factor in acute experimental pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Role of cytokines and their inhibitors in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Role of platelet activating factor in pathogenesis of acute pancreatitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Increased monocyte cytokine production in association with systemic complications in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Effectiveness of gabexate mesilate in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Acute pancreatitis: the substantial human and financial costs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

The role of cytokines in the pathogenesis of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Active interleukin-1 receptor required for maximal progression of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Decreased mortality of severe acute pancreatitis after proximal cytokine blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin 10 reduces the severity of acute pancreatitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

1 reference

7 January 2021

Role of tumor necrosis factor-alpha in disease states and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Interleukin 10 prevents necrosis in murine experimental acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Delayed tumor necrosis factor alpha blockade attenuates pulmonary dysfunction and metabolic acidosis associated with experimental gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Macrophage pacification reduces rodent pancreatitis-induced hepatocellular injury through down-regulation of hepatic tumor necrosis factor ? and interleukin-1?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

The physiologic consequences of macrophage pacification during severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

Platelet-activating factor involvement in the aggravation of acute pancreatitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970042-6

7 January 2021

10.1016/S0039-6109(05)70042-6

Identifiers

DOI

1 reference

release_s64vumpf5nabrfpdedvnjo6we4

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s64vumpf5nabrfpdedvnjo6we4

24 November 2022

mapped directly with Wikidata item

1 reference